These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 37698307)
1. Clinical Outcomes of Hospitalized Patients with SARS-CoV-2 Omicron Variant vs. Influenza A During Influenza Season 2021 to 2022: A Retrospective Observational Study. Atamna A; Berkov E; Drozdinsky G; Shochat T; Ben Zvi H; Eliakim-Raz N; Bishara J; Elis A Isr Med Assoc J; 2023 Sep; 25(9):585-589. PubMed ID: 37698307 [TBL] [Abstract][Full Text] [Related]
3. Distinguishing COVID-19 from seasonal influenza in patients under age 65 years-a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics. Zhong W; Wu Y; Yue W; Fang J; Xie B; Xu N; Lin M; Zhu X; Su Z; Chen Y; Li H; Li H Front Cell Infect Microbiol; 2023; 13():1179552. PubMed ID: 37533930 [TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea. Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106 [TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Clinical Outcomes Using Propensity Score Matching: Coronavirus Disease 2019 vs. Seasonal Influenza in Korea. Sim JK; Lee HS; Yang J; Gwack J; Kim BI; Cha JO; Min KH; Lee YS; J Korean Med Sci; 2024 Apr; 39(14):e128. PubMed ID: 38622937 [TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466 [TBL] [Abstract][Full Text] [Related]
7. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients. Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846 [TBL] [Abstract][Full Text] [Related]
8. Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study. Dickow J; Gunawardene MA; Willems S; Feldhege J; Wohlmuth P; Bachmann M; Bergmann MW; Gesierich W; Nowak L; Pape UF; Schreiber R; Wirtz S; Twerenbold R; Sheikhzadeh S; Gessler N PLoS One; 2023; 18(9):e0292017. PubMed ID: 37756299 [TBL] [Abstract][Full Text] [Related]
9. Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network. Kodde C; Bonsignore M; Schöndube D; Bauer T; Hohenstein S; Bollmann A; Meier-Hellmann A; Kuhlen R; Nachtigall I Infection; 2023 Feb; 51(1):119-127. PubMed ID: 35657531 [TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study. Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals. Leiner J; Pellissier V; Hohenstein S; König S; Schuler E; Möller R; Nachtigall I; Bonsignore M; Hindricks G; Kuhlen R; Bollmann A BMC Infect Dis; 2022 Oct; 22(1):802. PubMed ID: 36303111 [TBL] [Abstract][Full Text] [Related]
12. A Systematic Review and Clinical Presentation of Central Nervous System Complications of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Pediatric Patients During the Coronavirus Disease 2019 Pandemic in Israel. Jurkowicz M; Leibovitz E; Ben-Zeev B; Keller N; Kriger O; Sherman G; Amit S; Barkai G; Mandelboim M; Stein M Pediatr Neurol; 2024 Apr; 153():68-76. PubMed ID: 38335916 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients. Hu FH; Jia YJ; Zhao DY; Fu XL; Zhang WQ; Tang W; Hu SQ; Wu H; Ge MW; Du W; Shen WQ; Zhu B; Chen HL Clin Microbiol Infect; 2023 Jul; 29(7):835-844. PubMed ID: 36934872 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season. Tang CY; Boftsi M; Staudt L; McElroy JA; Li T; Duong S; Ohler A; Ritter D; Hammer R; Hang J; Wan XF Virology; 2022 Nov; 576():105-110. PubMed ID: 36206606 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel. Bieber A; Brikman S; Novack L; Ayalon S; Abu-Shakra M; Zeller L; Mader R; Sagy I Semin Arthritis Rheum; 2023 Feb; 58():152129. PubMed ID: 36462304 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Piroth L; Cottenet J; Mariet AS; Bonniaud P; Blot M; Tubert-Bitter P; Quantin C Lancet Respir Med; 2021 Mar; 9(3):251-259. PubMed ID: 33341155 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of influenza and COVID-19 inpatients in different phases of the SARS-CoV-2 pandemic: a single-centre retrospective case-control study. Bechmann L; Esser T; Färber J; Kaasch A; Geginat G J Hosp Infect; 2023 Aug; 138():1-7. PubMed ID: 37127148 [TBL] [Abstract][Full Text] [Related]
18. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection. Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150 [TBL] [Abstract][Full Text] [Related]
19. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022. Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225 [TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]